Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction

American Heart Journal

Volumn 136, Issue 6, 1998, Pages 972-981

  Lorenzoni, R ^a   Gistri, R ^a   Cecchi, F ^a   Olivotto, I ^a   Chiriatti, G ^a   Elliott, P ^a   McKenna, W J ^a   Camici, P G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY VASODILATING AGENT; DIPYRIDAMOLE;

ADULT; ARTICLE; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0032464683     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70152-8     Document Type: Article

References (46)

1. ED Wigle H Rakowski BP Kimball WG. Williams Hypertrophic cardiomyopathy: clinical spectrum and treatment Circulation 92 1995 1680 1692
2. FJ ten Cate J. Roelandt Progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy Am Heart J 97 1979 762 765
3. P Spirito BJ Maron RO Bonow SE. Epstein Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy Am J Cardiol 59 1987 123 129
4. M Tanaka H Fujiwara T Onodera D-J Wu Y Hamashima C. Kawai Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts and hypertrophic cardiomyopathy Br Heart J 55 1986 575 581
5. SM Factor J Butany MJ Sole ED Wigle WG Williams M. Rojkind Pathologic fibrosis and matrix connective tissue in the subaortic myocardium in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 17 1991 1343 1351
6. BJ Maron RO Bonow RO Cannon MB Leon SE. Epstein Hypertrophic cardiomyopathy: interrelations of clinical manifestation, pathophysiology, and therapy N Engl J Med 316 1987 780-9 844-52
7. BL Maron SE Epstein WC. Roberts Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries Am J Cardiol 43 1979 1086 1102
8. BF Waller BL Maron SE Epstein WC. Roberts Transmural myocardial infarction in hypertrophic cardiomyopathy: a cause of conversion from left ventricular asymmetry to symmetry and from normal size to dilated left ventricular cavity Chest 79 1981 461 465
9. A Pasternac J Noble Y Steulens R Elie C Henschke MG. Bourassa Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries Circulation 65 1982 778 789
10. RO Cannon DR Rosing BJ Maron MB Leon RO Bonow RM Watson Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures Circulation 71 1985 234 243
11. PT O’Gara RO Bonow BJ Maron BA Damske A Van Lingen SL Bacharach Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography Circulation 76 1987 1214 1223
12. TW von Dohlen LM Prisant MJ. Frank Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy Am J Cardiol 64 1989 498 503
13. Y Koga R Yamaguchi M Ogata K Kihara H. Toshima Decreased coronary vasodilatory capacity in hypertrophic cardiomyopathy determined by split dose thallium-dipyridamole myocardial scintigraphy Am J Cardiol 65 1990 1134 1139
14. P Camici G Chiriatti R Lorenzoni CR Bellina R Gistri G Italiani Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography J Am Coll Cardiol 17 1991 879 886
15. J Takata PJ Counihan JN Gane D Yoshimori T Chikamori T Ozawa Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain Am J Cardiol 72 1993 211 218
16. P Spirito P. Bellone Natural history of hypertrophic cardiomyopathy Br Heart J 72 suppl 1994 S10 S12
17. BJ Maron SE. Epstein Hypertrophic cardiomyopathy: a discussion of nomenclature Am J Cardiol 43 1979 1242 1244
18. G Rose P McCartney DD. Reid Self-administration of a questionnaire o n chest pain and intermittent claudication Br J Prevent Soc Med 31 1977 42 48
19. GA Diamond JS. Forrester Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease N Engl J Med 300 1979 1350 1358
20. R. Detrano Optimal use of literature knowledge to improve the Bayesian diagnosis of coronary artery disease J Clin Epidemiol 42 1989 1041 1047
21. NB Shiller PM Shah M Crawford A De Maria R Devereux H Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography J Am Soc Echocardiogr 2 1989 358 367
22. RC Bellina O Parodi P Camici PA Salvadori L Taddei L Fusani Simultaneous in vitro and in vivo of nitrogen-13-ammonia for the assessment of regional myocardial blood flow J Nucl Med 31 1990 1335 1343
23. LI Araujo AA Lammertsma CG Rhodes EO McFalls H Iida E Rechavia Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography Circulation 83 1991 875 885
24. JB West CT. Dollery Uptake of oxygen-15 labelled CO2 compared with carbon-11 labelled CO2 in the lung J Appl Physiol 17 1962 9 13
25. PG Camici F Cecchi R Gistri A Montereggi PA Salvadori A Dolara Dipyridamole-induced subendocardial underperfusion in hypertrophic cardiomyopathy assessed by positron emission tomography Coron Artery Dis 2 1991 837 841
26. PM Elliott GMC Rosano JS Gill PA Poole-Wilson JC Kaski WJ. McKenna Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy Heart 75 1996 179 183
27. RO Cannon V Dilsizian PT O’Gara JE Udelson WH Schenke A Quyyumi Myocardial metabolic, hemodynamic, and electrocardiographic significance reversible thallium-201 abnormalities in hypertrophic cardiomyopathy Circulation 83 1991 1660 1667
28. BJ Maron JK Wolfson SE Epstein WC Roberts Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy J Am Coll Cardiol 8 1986 545 547
29. EK Louie BJ. Maron Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: clinical significance, functional, and morphological features J Am Coll Cardiol 8 1986 57 65
30. M Grover-McKay M Schwaiger J Krivokapich JK Perloff ME Phelps HR. Shelbert Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 13 1989 317 324
31. CA Nienaber SS Gambhir FV Mody O Ratib SC Huang ME Phelps Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy Circulation 87 1993 1580 1590
32. ME. Phelps Emission computed tomography Semin Nucl Med 7 1977 337 365
33. RJ Domenech JIE Hoffman MIM Noble KB Saunders JR Henson S. Subijanto Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs Circ Res 25 1969 581 596
34. GD Buckberg DE Fixler JP Archie JIE. Hoffman Experimental subendocardial ischemia in dogs with normal coronary arteries Circ Res 30 1972 67 81
35. RJ Bache FR Cobb JC. Greenfield Myocardial blood flow distribution during ischemia-induced vasodilatation in the unanesthetized dog J Clin Invest 54 1974 1462 1472
36. FR Cobb RJ Bache JC. Greenfield Regional myocardial blood flow in awake dogs J Clin Invest 53 1974 1618 1625
37. A L’Abbate M Marzilli AM Ballestra PG Camici MG Trivella G Pelosi Opposite transmural gradients of coronary resistance and extravascular pressure in the working dog’s heart Cardiovasc Res 14 1980 21 29
38. S Nagata Y Park T Minamikawa C Yutani T Kamiya T Nishimura Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy Am Heart J 109 1985 1307 1322
39. BJ Maron P. Spirito Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history Am J Cardiol 72 1993 970 972
40. Guidelines for Clinical Use of Cardiac Radionuclide Imaging Report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging), developed in collaboration with the American Society of Nuclear Cardiology J Am Coll Cardiol 25 1995 521 547
41. JE Udelson RO Bonow PT O’Gara BJ Maron A Van Lingen SL Bacharach Verapamil prevents silent myocardial perfusion abnormalities during exercise in hypertrophic cardiomyopathy Circulation 79 1989 1052 1060
42. R Gistri F Cecchi L Choudhury A Montereggi D Sorace PA Salvadori Effect of verapamil treatment on absolute myocardial perfusion in hypertrophic cardiomyopathy Am J Cardiol 74 1994 363 368
43. 15 O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres Circulation 87 1993 512 525
44. EU Nitzsche Y Choi J Czernin CK Hoh S Huang HR. Schelbert Noninvasive quantification of myocardial blood flow in humans: a direct comparison of the N13-ammonia and the O15-water technique Circulation 93 1996 2000 2006
45. RC Bellina O Parodi P Camici Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow J Nucl Med 31 1990 1335 1343
46. LI Araujo AA Lammertsma CG Rhodes Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography Circulation 83 1991 875 885